alendronate has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pitocco, D | 2 |
| Ruotolo, V | 2 |
| Caputo, S | 2 |
| Mancini, L | 2 |
| Collina, CM | 1 |
| Manto, A | 2 |
| Caradonna, P | 2 |
| Ghirlanda, G | 2 |
| Collina, MC | 1 |
| Musella, T | 1 |
| Galli, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.[NCT04547348] | Phase 3 | 38 participants (Anticipated) | Interventional | 2020-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for alendronate and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy.
Topics: Acute Disease; Alendronate; Arthropathy, Neurogenic; Bone Density Conservation Agents; Bone Resorpti | 2008 |
1 trial available for alendronate and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial.
Topics: Acute Disease; Alendronate; Arthropathy, Neurogenic; Bone Resorption; Diabetic Neuropathies; Disabil | 2005 |